Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Temozolomide (Primary) ; Bevacizumab
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Apr 2013 Biomarkers information updated
- 29 Jun 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 29 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.